A general parametric approach to the meta-analysis of randomized clinical trials.

Meta-analysis provides a systematic and quantitative approach to the summary of results from randomized studies. Whilst many authors have published actual meta-analyses concerning specific therapeutic questions, less has been published about comprehensive methodology. This article presents a general parametric approach, which utilizes efficient score statistics and Fisher's information, and relates this to different methods suggested by previous authors. Normally distributed, binary, ordinal and survival data are considered. Both the fixed effects and random effects model for treatments are described.

[1]  P. McCullagh.  Regression Models for Ordinal Data , 1980 .

[2]  R. Collins,et al.  Blood pressure, stroke, and coronary heart disease Part 2, short-term reductions in blood pressure: overview of randomised drug trials in their epidemiological context , 1990, The Lancet.

[3]  N. Laird,et al.  Meta-analysis in clinical trials. , 1986, Controlled clinical trials.

[4]  S Greenland,et al.  Bias in the one-step method for pooling study results. , 1990, Statistics in medicine.

[5]  D. A. Sprott.  Normal likelihoods and their relation to large sample theory of estimation , 1973 .

[6]  S. Yusuf.  Obtaining medically meaningful answers from an overview of randomized clinical trials. , 1987, Statistics in medicine.

[7]  F. J. Anscombe.  Normal likelihood functions , 1964 .

[8]  R F Galbraith,et al.  A note on graphical presentation of estimated odds ratios from several clinical trials. , 1988, Statistics in medicine.

[9]  W. G. Cochran.  The combination of estimates from different experiments. , 1954 .

[10]  T C Chalmers,et al.  A comparison of statistical methods for combining event rates from clinical trials. , 1989, Statistics in medicine.

[11]  H. B. Mann,et al.  On a Test of Whether one of Two Random Variables is Stochastically Larger than the Other , 1947 .

[12]  R. Light.  Accumulating evidence from independent studies: what we can win and what we can lose. , 1987, Statistics in medicine.

[13]  R. Peto,et al.  Beta blockade during and after myocardial infarction: an overview of the randomized trials. , 1985, Progress in cardiovascular diseases.

[14]  P. Canner,et al.  An overview of six clinical trials of aspirin in coronary heart disease. , 1987, Statistics in medicine.

[15]  N F Boyd,et al.  Mammographic parenchymal pattern and breast cancer risk: a critical appraisal of the evidence. , 1988, American journal of epidemiology.